Yu, Wu & Jiang
Concise Report
129.0, 127.6, 126.3, 125.2, 123.2, 121.6. IR (KBr) νmax: 3015, 1661,
1455 964, 798, 677 cm–1; MS (EI, 70 eV): m/z (%) = 211 [M]+, 184,
167, 108, 82, 69.
2-Phenylbenzo[d]thiazole-6-carbonitrile (4ja).[31d] Yellow solid
(32 mg, 69%); mp 197—198 °C ; H NMR (400 MHz, CDCl3) δ: 8.22
1
(s, 1H), 8.12—8.09 (m, 3H), 7.72 (d, J = 8.5 Hz, 1H), 7.58—7.48 (m,
3H). 13C NMR (100 MHz, CDCl3) δ: 172.2, 156.4, 135.4, 132.6,
132.0, 129.5, 129.2, 127.8, 126.3, 123.8, 118.7, 108.5; IR (KBr) νmax
2923, 2228, 1647, 1463, 1260, 965, 831, 755, 675 cm–1; MS (EI, 70
eV): m/z (%) = 236 [M]+, 209, 164, 133, 104, 82, 69.
6-Methyl-2-phenylbenzo[d]thiazole (4ba).[38] White solid (35
mg, 77 %); mp 125—126 °C ; 1H NMR (400 MHz, CDCl3) δ: 8.08 (dd,
J = 6.6, 2.7 Hz, 2H), 7.96 (d, J = 8.3 Hz, 1H), 7.69 (s, 1H), 7.51—7.45
(m, 3H), 7.30 (d, J = 8.3 Hz, 1H), 2.50 (s, 3H). 13C NMR (100 MHz,
CDCl3) δ: 167.0, 152.3, 135.3, 135.2, 133.8, 130.7, 128.9, 127.9,
127.4, 122.7, 121.3, 21.5. IR (KBr) νmax: 2992, 2888, 1662, 1558,
1456, 961, 758, 677 cm–1; MS (EI, 70 eV): m/z (%) = 225 [M]+, 209,
180, 148, 121, 112, 77.
:
5-Methyl-2-phenylbenzo[d]thiazole (4ka).[38] White solid (33
mg, 73%); mp 145—146 °C ; 1H NMR (400 MHz, CDCl3) δ:
8.13—8.04 (m, 2H), 7.89 (s, 1H), 7.77 (d, J = 8.2 Hz, 1H),
7.53—7.46 (m, 3H), 7.22 (d, J = 8.2 Hz, 1H), 2.52 (s, 3H). 13C NMR
(100 MHz, CDCl3) δ: 168.2, 154.5, 136.4, 133.7, 132.0, 130.8,
129.0, 127.5, 126.8, 123.2, 121.1, 21.5; IR (KBr) νmax: 3058, 1658,
6-Methoxy-2-phenylbenzo[d]thiazole (4ca).[38] White solid
(31 mg, 65%); mp 116—117 °C ; 1H NMR (400 MHz, CDCl3) δ:
8.07—8.00 (m, 2H), 7.96 (d, J = 8.9 Hz, 1H), 7.50—7.43 (m, 3H),
7.34 (d, J = 2.0 Hz, 1H), 7.10—7.08 (m, 1H), 3.87 (s, 3H). 13C NMR
(100 MHz, CDCl3) δ: 165.5, 157.8, 148.6, 136.4, 133.7, 130.5,
128.9, 127.2, 123.7, 115,6, 104.1, 55.7. IR (KBr) νmax: 3035, 1423,
1244, 959, 844, 763, 677 cm–1; MS (EI, 70 eV): m/z (%) = 241 [M]+,
226, 198, 171, 120, 95, 77.
1454, 1250, 954, 762, 683 cm–1; MS (EI, 70 eV): m/z (%) = 225 [M]+,
209, 193, 165, 121, 112, 77.
5-Fluoro-2-phenylbenzo[d]thiazole (4la).[32a] White solid (32
mg, 69%); mp 111—112 °C ; 1H NMR (400 MHz, CDCl3) δ: 8.08 (dd,
J = 6.5, 2.8 Hz, 2H), 7.82 (dd, J = 8.8, 5.1 Hz, 1H), 7.75 (dd, J = 9.5,
2.3 Hz, 1H), 7.55—7.46 (m, 3H), 7.18—7.13 (m, 1H). 13C NMR (100
MHz, CDCl3) δ: 170.5, 162.0 (d, J = 241 Hz), 155.1 (d, J = 12 Hz),
133.4, 131.3, 130.5, 129.1, 127.5, 122.2 (d, J = 10 Hz), 113.9 (d, J =
25 Hz), 109.4 (d, J = 24 Hz); IR (KBr) νmax: 1560, 1455, 1240, 1138,
955, 876, 760, 681 cm–1; MS (EI, 70 eV): m/z (%) = 229 [M]+, 202,
185, 126, 114, 93, 69.
6-Fluro-2-phenylbenzo[d]thiazole (4da).[38] White solid (32
1
mg, 70%); mp 134—135 °C ; H NMR (400 MHz, CDCl3) δ: 8.06 (m,
2H), 8.01 (m, 1H), 7.58 (m, 1H), 7.55—7.43 (m, 3H), 7.26—7.19 (m,
1H). 13C NMR (100 MHz, CDCl3) δ: 167.8, 160.5 (d, J = 244 Hz),
150.8, 136.0 (d, J = 11 Hz), 133.4, 131.0, 129.0, 127.4, 124.1 (d, J =
10 Hz), 114.9 (d, J = 24Hz), 107.8 (d, J = 26 Hz); IR (KBr) νmax: 1661,
1468, 1290, 956, 832, 674 cm–1; MS (EI, 70 eV): m/z (%) = 229 [M]+,
202, 185, 152, 126, 101, 82, 69.
5-Chloro-2-phenylbenzo[d]thiazole (4ma).[38] White solid (30
mg, 62%); mp 135—136 °C ; 1H NMR (400 MHz, CDCl3) δ:
8.11—8.02 (m, 3H), 7.79 (d, J = 8.5 Hz, 1H), 7.50 (d, J = 4.6 Hz, 3H),
7.35 (d, J = 8.5 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ: 169.9, 155.0,
133.3, 133.2, 132.3, 131.3, 129.1, 127.6, 125.6, 123.0, 122.3; IR
(KBr) νmax: 2889 IR (KBr) νmax: 1266, 959, 756, 676 cm–1; MS (EI, 70
eV): m/z (%) = 245 [M]+, 210, 142, 122, 107, 77, 69, 63.
6-Chloro-2-phenylbenzo[d]thiazole (4ea).[29d] White solid (33
mg, 68%); mp 150—151 °C ; 1H NMR (400 MHz, CDCl3) δ:
8.08—8.06 (m, 2H), 7.98 (d, J = 8.7 Hz, 1H), 7.87 (d, J = 1.6 Hz, 1H),
7.54—7.47 (m, 3H), 7.46—7.44 (m, 1H). 13C NMR (100 MHz, CDCl3)
δ: 168.5, 152.7, 136.2, 133.2, 131.2, 131.1, 129.1, 127.5, 127.1,
123.9, 121.2; IR (KBr) νmax: 3069, 1650, 1472, 1288, 959, 825, 756,
674 cm–1; MS (EI, 70 eV): m/z (%) = 245 [M]+, 218, 209, 142, 107,
69.
5-Bromo-2-phenylbenzo[d]thiazole (4na).[31d] White solid (32
1
mg, 55%); mp 136—137 °C ; H NMR (400 MHz, CDCl3) δ: 8.22 (s,
1H), 8.10—8.03 (m, 2H), 7.74 (d, J = 8.5 Hz, 1H), 7.55—7.44 (m,
4H). 13C NMR (100 MHz, CDCl3) δ: 169.7, 155.3, 133.8, 133.2,
131.3, 129.1, 128.3, 127.6, 126.1, 122.6, 119.9; IR (KBr) νmax: 3072,
1719, 1457, 1255, 961, 880, 747, 690 cm–1; MS (EI, 70 eV): m/z (%)
= 289 [M]+, 210, 188, 146, 108, 77, 69, 63.
6-Bromo-2-phenylbenzo[d]thiazole (4fa).[38] White solid (38
mg, 66%); mp 157—158 °C ; 1H NMR (400 MHz, CDCl3) δ:
8.07—8.05 (m, 2H), 8.00 (d, J = 1.7 Hz, 1H), 7.90 (d, J = 8.7 Hz, 1H),
7.59—7.56 (m, 1H), 7.50—7.48 (m, 3H). 13C NMR (100 MHz, CDCl3)
δ: 168.5, 153.0, 136.6, 133.1, 131.2, 129.8, 129.1, 127.5, 124.3,
124.1, 118.7; IR (KBr) νmax: 3064, 1650, 1473, 1298, 1230, 959, 820,
753, 676 cm–1; MS (EI, 70 eV): m/z (%) = 289 [M]+, 210, 188, 144,
107, 77, 69.
4,6-Dimethyl-2-phenylbenzo[d]thiazole (4oa).[32a] White solid
(37 mg, 78%); mp 85—86 °C ; 1H NMR (400 MHz, CDCl3) δ: 8.10 (d,
J = 6.6 Hz, 2H), 7.55—7.43 (m, 4H), 7.11 (s, 1H), 2.78 (s, 3H), 2.46
(s, 3H). 13C NMR (100 MHz, CDCl3) δ: 165.6, 151.6, 135.2, 135.1,
134.1, 132.7, 130.5, 128.9, 128.5, 127.4, 118.7, 21.5, 18.3; IR (KBr)
νmax: 3040, 2921, 1666, 1593, 1451, 1320, 12131, 962, 755, 683
cm–1; MS (EI, 70 eV): m/z (%) = 239 [M]+, 224, 206, 135, 121, 91,
77.
Methyl 2-phenylbenzo[d]thiazole-6-carboxylate (4ga).[31d]
1
White solid (34 mg, 64%); mp 159—160 °C ; H NMR (400 MHz,
4,6-Dichloro-2-phenylbenzo[d]thiazole (4pa).[38] White solid
CDCl3) δ: 8.62 (s, 1H), 8.19—8.07 (m, 4H), 7.51 (d, J = 5.5 Hz, 3H),
3.97 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 171.5, 166.6, 157.0,
134.9, 133.1, 131.6, 129.1, 127.7, 127.5, 126.9, 123.8, 122.8, 52.3;
IR (KBr) νmax: 3216, 1708, 1453, 1271, 1109, 965, 759 cm–1; MS (EI,
70 eV): m/z (%) = 269 [M]+, 238, 210, 183, 166, 108, 63.
1
(42 mg, 75%); mp 152—153 °C ; H NMR (400 MHz, CDCl3) δ: 8.10
(d, J = 6.4 Hz, 2H), 7.77 (s, 1H), 7.54—7.46 (m, 4H). 13C NMR (100
MHz, CDCl3) δ 169.2, 149.9, 137.1, 132.9, 131.6, 130.9, 129.1,
128.5, 127.8, 127.1, 119.8; IR (KBr) νmax: 3076, 1710, 1560, 1446,
1257, 962, 858, 757, 676 cm–1; MS (EI, 70 eV): m/z (%) = 279 [M]+,
244, 209, 176, 141, 106, 97, 77.
2-Phenyl-6-(trifluoromethyl)benzo[d]thiazole (4ha).[38] Yellow
solid (45 mg, 80%); mp 160—161 °C ; 1H NMR (400 MHz, CDCl3) δ:
8.17 (s, 1H), 8.13 (d, J = 8.6 Hz, 1H), 8.11—8.04 (m, 2H), 7.72 (d,
J = 8.6 Hz, 1H), 7.56—7.45 (m, 3H). 13C NMR (100 MHz, CDCl3) δ:
171.0, 156.0, 135.0, 132.9, 131.6, 129.1, 127.7, 142.2 (q, J = 32
Hz), 124.2 (q, J = 271 Hz), 123.4, 123.2 (q, J = 3 Hz), 119.2 (q, J = 4
Hz); IR (KBr) νmax: 2890, 1663, 1474, 1307, 1111, 962, 838, 756,
677 cm–1; MS (EI, 70 eV): m/z (%) = 279 [M]+, 260, 210, 176, 157,
132, 77, 69.
6-Chloro-4-fluoro-2-phenylbenzo[d]thiazole (4qa).[38] Yellow
solid (30 mg, 57%); mp 156—158 °C ; 1H NMR (400 MHz, CDCl3) δ:
8.06 (m, 2H), 7.61 (s, 1H), 7.49 (m, 3H), 7.19 (m, 1H). 13C NMR
(100 MHz, CDCl3) δ: 168.9, 155.1 (d, J = 259 Hz), 141.7 (d, J = 13
Hz), 138.2 (d, J = 4 Hz), 132.7, 131.5, 131.0 (d, J = 9 Hz), 129.0,
127.7, 117.1 (d, J = 5 Hz), 113.5 (d, J = 21 Hz); IR (KBr) νmax: 3078,
1561, 1437, 1234, 982, 840, 757, 678 cm–1; MS (EI, 70 eV): m/z (%)
= 263 [M]+, 236, 227, 160, 125, 81, 69.
6-Nitro-2-phenylbenzo[d]thiazole (4ia).[31d] Yellow solid (31
1
2-Phenylthiazolo[5,4-c]pyridine (4ra).[38] White solid ( 26 mg,
mg, 61%); mp 191—193 °C ; H NMR (400 MHz, CDCl3) δ: 8.82 (s,
1
1H), 8.36 (d, J = 9.0 Hz, 1H), 8.13—8.10 (m, 3H), 7.59—7.51 (m,
3H). 13C NMR (100 MHz, CDCl3) δ: 173.7, 157.8, 144.9, 135.3,
132.7, 132.2, 129.3, 127.9, 123.3, 121,9, 118.2; IR (KBr) νmax: 2997,
1655, 1514, 1328, 956, 843, 755, 676 cm–1; MS (EI, 70 eV): m/z (%)
= 256 [M]+, 226, 210, 198, 183, 139, 107, 95, 77.
61%); mp 136—137 °C ; H NMR (400 MHz, CDCl3) δ: 9.18 (s, 1H),
8.64 (d, J = 5.6 Hz, 1H), 8.19—8.04 (m, 2H), 7.91 (d, J = 5.6 Hz, 1H),
7.59—7.43 (m, 3H). 13C NMR (100 MHz, CDCl3) δ: 173.3, 158.8,
145.9, 144.1, 132.7, 132.1, 132.0, 129.2, 128.0, 117.3; IR (KBr) νmax
:
3031, 1659, 1550, 1462, 1242, 963, 841, 764, 649 cm–1; MS (EI, 70
1162
© 2019 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Chin. J. Chem. 2019, 37, 1158-1166